CSULB
Long Beach, California, 90840, United States
Enrolling by Invitation
NCT Number: NCT06923384
SBI for PSM and PSD
A pilot randomized controlled trial to assess the feasibility, acceptability, and impact of screening and brief intervention to address prescription stimulant misuse and diversion among college students.
Enrolling by Invitation
Interested in participating?
Request InfoKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 1
Primary location
About this study
A screening and brief intervention including a control group, face-to-face group, and e-intervention group where the focus is prevention or brief intervention or referral to treatment related to students prescription stimulant misuse and diversion behaviors. Students will complete assessments at three time points, and the health providers who implement the intervention will also complete assessments.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age 18 and student at the campus serving as the intervention site; Passive recruitment: Student has a scheduled appointment for a physical/wellness exam. Active recruitment: Student has a past 3 month history of PSM or PSD.
Exclusion criteria
Any eligible student who, during the course of the session, demonstrates the need for immediate mental health services, will have the study session terminated so that participant can receive needed care.
Treatment and study plan
F2F
BehavioralAfter T1 assessment, students meet with a trained provider and receive prevention or brief intervention. Students then complete assessments at two additional times.
eSBI
BehavioralAfter T1 assessment, students watch and respond to a prevention or brief intervention video series. Students then complete assessments at two additional times.
Control
BehavioralStudents complete the assessments at each time point, but do not receive any intervention or informational material.
Primary outcomes
-
Prescription Stimulant Misuse
Time frame: 30 days
Students report on their experience with prescription stimulant misuse behaviors. PSM is assessed at T1, pre-intervention, and T3, 30-Days post intervention.
-
Prescription Stimulant Diversion
Time frame: 30 days
Students report on their experience with prescription stimulant diversion behaviors. PSD is assessed at T1, pre-intervention, and T3, 30-Days post intervention.
Secondary outcomes
-
PSM Intentions
Time frame: 30 days
Intention to engage in PSM is measured at T1 (pre-intervention), T2 (immediate post), and T3 (30 Day post intervention)
-
PSD Intentions
Time frame: 30 days
Intention to engage in PSM is measured at T1 (pre-intervention), T2 (immediate post), and T3 (30 Day post intervention).
Sponsors and collaborators
Lead sponsor
California State University, Long Beach
Other
Collaborators
- National Institute on Drug Abuse (NIDA)
Registry information
Official study title
Screening and Brief Intervention for Prescription Stimulant Misuse and Diversion: Refining and Piloting a Curriculum for College Health Providers
Important dates
- Study start
- 2024
- Primary completion
- 2025
- Study completion
- 2026
- First posted
- Apr 11, 2025
- Registry last updated
- May 4, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.